LDL-like nanoparticles
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LDL-like nanoparticles, covering 2021-01-14 to 2021-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) [Phase 1, Phase 2]